Medicaid Expansion is a Red and Blue State Issue November 27, 2024 Issue Brief With President-elect Trump returning to the White House and Republicans controlling Congress, significant changes to the Medicaid expansion are expected. This data note provides key facts on the Medicaid expansion, highlighting the financial and coverage impacts of any changes across states that voted for President-elect Trump and those that voted for Vice President Harris.
KFF Survey of Women Voters Dashboard June 20, 2024 Page The KFF Survey of Women Voters examines differing motivations, attitudes, and experiences among women by race and ethnicity, age, and partisanship heading into the 2024 election nationally and in two battleground states, Arizona and Michigan.
Why Medicare Drug Price Negotiation Matters for Potential Medicare Coverage of Obesity Drugs December 2, 2024 Quick Take It’s quite likely that one of these popular anti-obesity medications will be selected for negotiation in the next round of Medicare’s relatively new drug price negotiation program.
KFF Health Misinformation Monitor Volume 4 July 25, 2024 Page In this Monitor, we explore how ongoing misinformation about the safety and efficacy of COVID-19 vaccines may affect the acceptance of new vaccine recommendations. First, we examine the false and misleading claims underlying the Kansas Attorney General’s lawsuit against Pfizer. We also discuss the CDC’s most recent vaccine.
KFF Health Misinformation Monitor Volume 3 July 11, 2024 Page This edition focuses on intentionally false or misleading information online and its potential impact on public trust in health care. We share a recent report that exposed a covert U.S. military social media disinformation campaign in the Philippines that may have undermined public confidence in vaccines. We also examine how false claims about sunscreen and non-FDA-approved “miracle cures” may be discouraging people from taking important preventative measures and seeking legitimate medical treatment. Finally, we explore the rise of counterfeit diabetes and weight-loss drugs like Ozempic and the potential impact on trust in the pharmaceutical supply chain.
KFF Health Misinformation Monitor Volume 1 June 13, 2024 Page This first edition of the Health Misinformation Monitor explores misinformation about raw milk amid bird flu outbreaks on dairy farms, false vaccine narratives that continue to spread, and legal challenges against abortion pill reversal claims. Additionally, a growing number of states have required public schools to show fetal development videos that some have called biased and inaccurate. This Monitor report also provides a snapshot of new KFF misinformation polling on TikTok and discusses the early challenges faced by The World Health Organization’s new AI tool SARAH in providing accurate answers to health questions.
What to Know Ahead of the Supreme Court Case on Youth Access to Gender Affirming Care November 26, 2024 Issue Brief This brief provides background on gender affirming care and state bans, explains the legal challenge to the Tennessee law, and explores the potential Supreme Court ruling and impact on access across the country.
Election 2024 April 5, 2024 Topic Landing Page This topic page houses KFF resources that are relevant to policy debates in the 2024 elections, including those about abortion, the Affordable Care Act, and Medicare.
Medicaid Postpartum Coverage Extension Tracker December 2, 2024 Issue Brief This page tracks recent state actions to extend Medicaid postpartum coverage, including approved and pending 1115 waivers, legislation that will require the state to seek federal approval through a SPA or 1115 waiver, submitted and approved SPAs, and coverage financed solely with state funds.
Medicare Spending for Dual-Eligible Individuals in Traditional Medicare as a Share of Total Traditional Medicare Spending December 3, 2024 State Indicator Dual eligibles, Dually eligible, Dually enrolled, duals